Azilsartan medoxomil
NDC 70748-237, Azilsartan medoxomil, tablet, from Lupin Pharmaceuticals, Inc..
- Product NDC
- 70748-237
- Status
- Listed
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA214489
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70748-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AZILSARTAN KAMEDOXOMIL80 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Decreased Blood Pressure [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70748-237-06 | 70748023706 | 30 TABLET in 1 BOTTLE (70748-237-06) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b1c8de43-3b26-408f-8c7e-6c7d76348199
Use it
Look up 70748-237 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70748-237 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70748-237. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.